Hepatitis C - ViRexx Presents Hepatitis C Chimigen'TM' Technology at Baculovirus ...

ViRexx Presents Hepatitis C Chimigen'TM' Technology at Baculovirus ...
Genetic Engineering News, NY - Feb 22, 2006... The presentation is titled "Properties of a Chimigen(TM) Vaccine Produced in Insect Cells for the Treatment of Chronic Hepatitis C Infections". ...

Idenix Announces Thirteen Data Presentations at the 2006 European ...
PR Newswire (press release), NY - Mar 17, 2006... will present "Absence of Effect of Pegylated Interferon Alfa-2b on the Pharmacokinetics of Valopicitabine (NM283) in Patients with Chronic Hepatitis C" in the ...

Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2005 ...
PR Newswire (press release), NY - Feb 23, 2006... ANA975 designed to evaluate the safety and tolerability of ANA975 and the viral load reduction achieved in patients with chronic hepatitis C over 28 days. ...

MIGENIX Reports Third Quarter Fiscal Year 2006 Results
MSN Money - Mar 8, 2006... development programs, with two phase II clinical outcomes expected this year in our MX-3253 program for the treatment of chronic hepatitis C virus infections ...